Log in Join free

Author

Yu-Heng Zhang

View on Semantic Scholar

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Targeting the PRMT5-CBX8 axis overcomes dual barriers of CD8⁺ T cell exclusion and tumor stemness for sensitizing TNBC to anti-PD-1 therapy.

Cong-Cong Chen, Yu-Heng Zhang, Chang Liu et al. · Oncogene · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.